Navigation Links
NUCRYST Pharmaceuticals announces year-end results
Date:2/14/2008

(777)

Other 1,189 71 (13) (212)

Accounts payable

and accrued

liabilities (5,095) (1,079) 668 (2,376)

Accounts payable

and accrued

liabilities to

related party (72) (513) (177) (969)

-------------------------------------------------------------------------

Cash used in operating

activities (2,445) (794) (2,690) (12,587)

-------------------------------------------------------------------------

Investing activities

Restricted cash (4) (1) (5) (5)

Purchase of

short-term

investments - - - (22,191)

Maturity of

short-term

investments - - - 22,748

Capital

expenditures (336) (632) (1,920) (4,978)

Intangible assets (10) (32) (66) (153)

-------------------------------------------------------------------------

Cash used in

investing activities (350) (665) (1,991) (4,579)

-------------------------------------------------------------------------

Financing activities

Issuance of common

shares, net of

share issuance

costs - 36 12 286

Deferred lease

inducement - - 822 -

-------------------------------------------------------------------------

Cash provided from

financing activities - 36 834 286

------------------------------------------------------------------------- <
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. NUCRYST Pharmaceuticals announces 2007 third quarter results
2. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. NUCRYST and Smith & Nephew Revise Agreements
4. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
5. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
6. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
7. American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals
8. MedThink Communications Selected by Salix Pharmaceuticals to Launch New Product
9. Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program
10. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
11. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...rter financial results -, LAVAL, QC, July 25 /PRN...DAQ: DDSS) today announced that it will host a con... to discuss its second quarter 2008,financial resu... financial,results via news release at approximate...nce call by telephone, dial 416-646-3095 or,1-800-...
(Date:7/25/2008)...erweight or obese is not only a personal issue tha... issue that impacts other people in society. A new...eveals that the extra Medicare cost associated wit...ant financial burden on tax payers, costing up to ...current Medicare population. , The article,s fi...
(Date:7/25/2008)...Fourth Annual Physician On-Call Pay ...swire/ -- Sullivan, Cotter and Associates, Inc.,ha...on-call pay rates and,practices, the 2008 Physicia...th data from 132 healthcare organizations nationwi...ates paid for 33 physician specialty areas along,w...
(Date:7/25/2008)...ire/ -- Sagent Pharmaceuticals, Inc.,a privately-...nced that it,has launched amiodarone HCl injection...e treatment and prophylaxis of frequently recurrin...table ventricular,tachycardia -- a potentially lif...arone HCl injection will be available immediately ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
...imed in treating AIDS patients using a herbal conc...se in white blood cell count. // Dr P L Meenakshi... reporters that the Herbal medicine helped HIV pa...(lymphocyte 4 - white blood cell) count increased ...
...lous kitten, when it comes to protecting her hands...f young ladies who drape themselves all over the r...at she would rather quit singing forever than lose...she gets really annoyed when girls flirt with her ...
...ded a grant of $30,000 to Medical College of Georg...understand the usefulness of online information sy...hether an online information system woulc be helpu...G was among 60 institutions invited to apply and t...
...essor and director of research in Virginia Commonw...ne reported that it will be fruitful // and more l...oving the medical facilities and provided the exis...ress allocates funds to the National Institute of ...
Other Medicine News:Health News:Online information system for patients 2Health News:Stop spending on new treatments; allocate funds to improve the existing treatments. 2
(Date:7/24/2008)... New JIT Enrollment Program Speeds Oncology... Pharmatech, Inc., a Research Management,Organizat...ceutical,companies to provide research and site ma...the Just-in-Time (JIT) enrollment strategy. The ne...: follicular Non-Hodgkin,s,Lymphoma, Metastatic Br...
(Date:7/24/2008)... NEW YORK, July 24 /- Mac...y announced results of a Phase 2 clinical trial,in...multi-center,open-label efficacy and safety study...treatment of onychomycosis (nail fungus). The comp...complete cure" defined as,negative mycology (negat...
(Date:7/23/2008)... - Nexavar is First Approved Systemic Therapy to... Calif., July 23 /-,Bayer H..., Inc. (Nasdaq:,ONXX) today announced that The New...a Phase 3 trial demonstrating that Nexavar(R) (sor...th by 31 percent in patients with,unresectable hep...
(Date:7/23/2008)... SEATTLE, July 23 /- Sound Pharmace...g Application with the FDA for the clinical,testin...prevention of,chemotherapy induced hearing loss or... SPI-3005, will be tested in advanced stage lung c...platinum based chemotherapy.,This marks the second...
Breaking Medicine Technology:Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Rocky water source 3607 1Rocky water source 3607 2Sex offenders register provides limited protection for children 21576 1Sex offenders register provides limited protection for children 21576 2Raloxifene Cuts Risk of Certain Type of Breast Cancer 21573 1Raloxifene Cuts Risk of Certain Type of Breast Cancer 21573 2Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration 21570 1Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration 21570 2
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. Murphy eye. High volume/low pressure cuff. Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Steri
...ser resistant foam surrounds the lower 17cm of tub...16") long, Single Use. The tracheal tube is design...within the operating site, while maintaining contr...ser-guard of approx. 17cm in length proximal to th...
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. St
...l Anesthetic, ,Designed for adolescent and adult ...tional lumen and injection port for spray applicat...., ,SHERIDAN offers three endotracheal tubes desi...oring or medication delivery without additional ad...
Medicine Products: